___

• 1- O' Brien CS, Me Lellan AT. Myths about the treatment of addiction. The Lancet 1996; 347: 2340-2347
• 2- Berridge KC, Venier IL, Robinson TE. Taste reactivity analysis of 6-hydroxydopamine-induced aphagia: implications for arousal and anhedonia hypothesis of dopamine function. Behav Neurosci. 1989 Feb; 103:36-45
• 3- Robinson TE, Berridge KC. The neural basis of drug craving: an incentive- sensitization theory of addiction. Brain Res Brain Res Rev 1993 Sep- Dec; 18:247-291
• 4- Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning or icentive salience? Brain Res Brain Res Rev 1998 Dec; 28: 309-69
• 5- Robinson TE, Berridge KC. The psycohology and neurobiology of addiction: an incentive - sensitization view. Addiction 2000; 95 (supl2 ):91 - 117.
• 6- Robinson TE, Berridge KC Incentive-sensitization and addiction Addiction 2001; Jan; 96:103-114
• 7- Lubman Dl, Peters LA Atentional bias for drug cues in opiate dependence. Psychol Med 2000; 30:169-175.
• 8- Robinson TE, Berridge KC. Addiction. Ann Rev Psycohol 2003; 59:25-53.
• 9- Johnson BR. Psychological addiction, addictive character, and addictive personality disorder: A Nosology of addictive disorders. Canadian Journal of Psychoanalysis 2003 Spring-1:135-160
• 10- Frances R, Frances J. Textbook of Substance Abuse Treatment Galanter M, Kleber HD (editors) 2. baskı. Washington, DC. American Psychiatric Pres, Inc. 1999: 309-321
• 11- Marinelli S,Pascucci T Activation of TRPV1 in the VTA excites dopaminergic neurons and increases chemical and noxious induced dopamine release in the nucleus accumbens. Neuropsychopharmacology 2005; 30: 864-70.
• 12- Boye SM. Mesencephalic substrate of reward: lesion effects. Behav Brain Res 2005; 156: 31-43.
• 13- Johnson B. Psychological Addiction, Physical Addiction, Addictive Character, and Addictive Personality Disorder: A nosology of addictive disorders. Canadian Journal of Psychoanalysis 2003 Spring; 2:135-160.
• 14- McDonald AF, Billington CJ. Alterations in food intake by opioid and dopamine signaling pathways between the ventral tegmental area and the shell of the nuclus accumbens. Brain Res 2004; 1018:78-85.
• 15- Leschner Al. Addiction is aBrain Disease and It Matters. Science 1997; 278: 45-47.
• 16- Johnson BR. Drug dreams: A neuropsychoanalytic hypothesis. 2001; 49:75-96.
• 17- HeidbrederCA,HaganJJ.Novelpharmacotherpeutic approaches for the treatment of drug addiction and craving. Curr Opin Pharmacol 2005; 5:107-18.
• 18- Weiss F. Neurobiology of craving, conditioned reward and relapse. Curr Opin Pharmacol 2005; 5:9-19.
• 19- Jaffe JH, Jaffe AB Textbook of Substance Abuse Treatment Galanter M, Kleber HD(editors) 2. baskı. Washington, DC. American Psychiatric Pres, Inc. 1999:11-19.
• 20- Pelebat ML, Johnson A. Images of desire: food cravin activation during fMRI. Neuroimage 2004; 23:1486-1493.
• 21- Lİ SP, Park MS. Chronic nicotine and smoke treatment modulate dopaminergic activities in the ventral tegmental area and nucleus accumbens and GABA type B receptor expression of the rat prefrontal cortex. J Neurosci Res 2004; 78: 868- 879.
• 22- Choi K, Clement RL Simultaneous AMPA/kainate receptor blockade and D2/3 recepror stimulation in the nucleus accumbens decreases brain stimulation reward in rats. Behav Brain Res 2005;158:79-88.
• 23- He DY, McGough NN. Glial cell line derived neurotrophic factor mediates the desirable actions of the antiaddiction drug ibogaine against alcohol consumption. J Neurosci 2005; 25: 619-628.
• 24- Wolf ME, Sun X . Psychomotor stimulants and neuronal plasticity. Neuropsychopharmacology. 2004; 47 (Suppl.1): 61-79
• 25- Watanabe T, Morimoto K. Kindling of the ventral tegmental area induces supersensivity in the central dopamine system. Brain Res. 2004; 1003:194-198.
• 26- Tupala E, Tiihonrn J. Dopamine and alcoholism: neurobiological basis of ethanol abuse. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28:1221-1247.
• 27- Jacpbsen CK, Krystal JH. Effects of smoking and smoking abstinence on cognition in adolescant tobacco smokers. Biol Psychiatry 2005; 57:56-66.
• 28- Lee J, Um Y. Nicotine craving and cue exposure therapy by using virtual environments. Cyberpsychol Behav 2004; 7: 705-713.
• 29- Waters AJ, Shiffman S. Cue provoked craving and nicotine replacement therapy in smoking cessation. J Consult Clin Psychol 2004; 72:1136- 1143.
• 30- Lai S,Lai H J. The association between cigarette smoking and drug abuse in the United States. Addict DİS 2000; 19: 11-24.
• 31- Peron R. Neden Psikanaliz. Tekin AT (çeviren). 1. Baskı, İstanbul: İthaki Yayınları, 2003; 115-120.
• 32- Freud S. Düşlem Yorumu. Kapkın E (çeviren). 2. Baskı, İstanbul: Payel Yayınevi. 1996; 126-138.
• 33- Persico AM. Predictors of smoking cessation in a sample of Italian smokers. Int J Addict 1992; 27: 683-695.
• 34- Pace-Schott EF, Stickgold R. Sleep quality detoriates over a binge -abstinence cycle in chronic smoked cocaine users. Psychopharmacology(Berl) 2005; 179:873-883.
• 35- Solms M. New findings on the neurological organization of dreaming: implications for psychoanalysis. Psychoanal Q. 1995; 64: 43-67.
• 36- Solms M. Dreaming and REM sleep are controlled by different brain mechanisms. Behav Brain Sci 2000 Dec; 23:843-50 discussion 904-1121.
• 37- Yee T, Perantie DC. Drug dreams in outpatients with bipolar disorder and cocaine dependence. J Nerv Ment DİS 2004; 192:238-242.
• 38- Flowers LK, Zweben JE. The dream interview method in addiction recovery. Atreatment guide. J Subst Abuse Treat 1996;13:99-105.
• 39- Flowers LK, Zweben JE. The changing role of using dreams in addiction recovery. J Subst Abuse Treat 1998;15:193-200.
• 40- Christo G, Franey C. Addicts drug related dreams: their frequency and relationship to six months outcomes. Subst Use Misuse1996; 31:1-15.
• 41- Jerry PA. Psychodynamic psychotherapy of the intravenous cocaine abuser. J Subst Abuse Treat 1997,-14:319-32.
• 42- Jerry PA. Dynamic change in crisis intervention Am J Psychother. 1998; 52:437-449.